These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 17931704)

  • 1. Regenerative potential of allopregnanolone.
    Wang JM; Liu L; Irwin RW; Chen S; Brinton RD
    Brain Res Rev; 2008 Mar; 57(2):398-409. PubMed ID: 17931704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regeneration in a degenerating brain: potential of allopregnanolone as a neuroregenerative agent.
    Wang JM; Irwin RW; Liu L; Chen S; Brinton RD
    Curr Alzheimer Res; 2007 Dec; 4(5):510-7. PubMed ID: 18220513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic potential of neurogenesis for prevention and recovery from Alzheimer's disease: allopregnanolone as a proof of concept neurogenic agent.
    Brinton RD; Wang JM
    Curr Alzheimer Res; 2006 Jul; 3(3):185-90. PubMed ID: 16842093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Allopregnanolone reverses neurogenic and cognitive deficits in mouse model of Alzheimer's disease.
    Wang JM; Singh C; Liu L; Irwin RW; Chen S; Chung EJ; Thompson RF; Brinton RD
    Proc Natl Acad Sci U S A; 2010 Apr; 107(14):6498-503. PubMed ID: 20231471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allopregnanolone promotes regeneration and reduces β-amyloid burden in a preclinical model of Alzheimer's disease.
    Chen S; Wang JM; Irwin RW; Yao J; Liu L; Brinton RD
    PLoS One; 2011; 6(8):e24293. PubMed ID: 21918687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preclinical analyses of the therapeutic potential of allopregnanolone to promote neurogenesis in vitro and in vivo in transgenic mouse model of Alzheimer's disease.
    Brinton RD; Wang JM
    Curr Alzheimer Res; 2006 Feb; 3(1):11-7. PubMed ID: 16472197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allopregnanolone restores hippocampal-dependent learning and memory and neural progenitor survival in aging 3xTgAD and nonTg mice.
    Singh C; Liu L; Wang JM; Irwin RW; Yao J; Chen S; Henry S; Thompson RF; Brinton RD
    Neurobiol Aging; 2012 Aug; 33(8):1493-506. PubMed ID: 21803451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The neurosteroid allopregnanolone is reduced in prefrontal cortex in Alzheimer's disease.
    Marx CE; Trost WT; Shampine LJ; Stevens RD; Hulette CM; Steffens DC; Ervin JF; Butterfield MI; Blazer DG; Massing MW; Lieberman JA
    Biol Psychiatry; 2006 Dec; 60(12):1287-94. PubMed ID: 16997284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroregenerative mechanisms of allopregnanolone in Alzheimer's disease.
    Irwin RW; Wang JM; Chen S; Brinton RD
    Front Endocrinol (Lausanne); 2011; 2():117. PubMed ID: 22654847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allopregnanolone as regenerative therapeutic for Alzheimer's disease: translational development and clinical promise.
    Irwin RW; Brinton RD
    Prog Neurobiol; 2014 Feb; 113():40-55. PubMed ID: 24044981
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allopregnanolone-induced rise in intracellular calcium in embryonic hippocampal neurons parallels their proliferative potential.
    Wang JM; Brinton RD
    BMC Neurosci; 2008 Dec; 9 Suppl 2(Suppl 2):S11. PubMed ID: 19090984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beneficial effects of quetiapine in a transgenic mouse model of Alzheimer's disease.
    He J; Luo H; Yan B; Yu Y; Wang H; Wei Z; Zhang Y; Xu H; Tempier A; Li X; Li XM
    Neurobiol Aging; 2009 Aug; 30(8):1205-16. PubMed ID: 18079026
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Age-related expression of calcium/calmodulin-dependent protein kinase II A in the hippocampus and cerebral cortex of senescence accelerated mouse prone/8 mice is modulated by anti-Alzheimer's disease drugs.
    Zhang GR; Cheng XR; Zhou WX; Zhang YX
    Neuroscience; 2009 Mar; 159(1):308-15. PubMed ID: 18721865
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel transgenic mouse expressing double mutant tau driven by its natural promoter exhibits tauopathy characteristics.
    Rosenmann H; Grigoriadis N; Eldar-Levy H; Avital A; Rozenstein L; Touloumi O; Behar L; Ben-Hur T; Avraham Y; Berry E; Segal M; Ginzburg I; Abramsky O
    Exp Neurol; 2008 Jul; 212(1):71-84. PubMed ID: 18490011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Powerful beneficial effects of macrophage colony-stimulating factor on beta-amyloid deposition and cognitive impairment in Alzheimer's disease.
    Boissonneault V; Filali M; Lessard M; Relton J; Wong G; Rivest S
    Brain; 2009 Apr; 132(Pt 4):1078-92. PubMed ID: 19151372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathophysiology of neuronal energy crisis in Alzheimer's disease.
    de la Torre JC
    Neurodegener Dis; 2008; 5(3-4):126-32. PubMed ID: 18322369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protection against cognitive deficits and markers of neurodegeneration by long-term oral administration of melatonin in a transgenic model of Alzheimer disease.
    Olcese JM; Cao C; Mori T; Mamcarz MB; Maxwell A; Runfeldt MJ; Wang L; Zhang C; Lin X; Zhang G; Arendash GW
    J Pineal Res; 2009 Aug; 47(1):82-96. PubMed ID: 19538338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nobiletin, a citrus flavonoid, improves memory impairment and Abeta pathology in a transgenic mouse model of Alzheimer's disease.
    Onozuka H; Nakajima A; Matsuzaki K; Shin RW; Ogino K; Saigusa D; Tetsu N; Yokosuka A; Sashida Y; Mimaki Y; Yamakuni T; Ohizumi Y
    J Pharmacol Exp Ther; 2008 Sep; 326(3):739-44. PubMed ID: 18544674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genomic analysis of response to traumatic brain injury in a mouse model of Alzheimer's disease (APPsw).
    Crawford FC; Wood M; Ferguson S; Mathura VS; Faza B; Wilson S; Fan T; O'Steen B; Ait-Ghezala G; Hayes R; Mullan MJ
    Brain Res; 2007 Dec; 1185():45-58. PubMed ID: 17961517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allopregnanolone preclinical acute pharmacokinetic and pharmacodynamic studies to predict tolerability and efficacy for Alzheimer's disease.
    Irwin RW; Solinsky CM; Loya CM; Salituro FG; Rodgers KE; Bauer G; Rogawski MA; Brinton RD
    PLoS One; 2015; 10(6):e0128313. PubMed ID: 26039057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.